Acute acneiform eruption induced by interferon beta-1b during treatment for multiple sclerosis

Abstracts

Multiple sclerosis is an inflammatory demyelinating disease of presumed autoimmune origin that affects the central nervous system. The main form of therapy is based on the use of immunomodulators such as interferon beta, which are usually well tolerated. Skin manifestations resulting from treatment with interferon beta-1b consist principally of reactions at the site of subcutaneous application of the drug. The present case report describes a female patient who developed an acneiform eruption resulting from treatment with interferon beta-1b.

Acneiform eruptions; Interferon-beta; Multiple sclerosis; Therapeutics